农村与非农村癌症患者放疗不依从及生存相关的社会人口学与临床因素
本研究基于一家安全网学术医学中心的肿瘤登记、病历与理赔数据,纳入3077例癌症患者,按美国农业部2013年城乡连续谱代码划分农村与非农村。研究采用Cox比例风险模型比较7种不依从定义,以缺失分次数占比拟合最佳,并分析不依从与生存的相关因素。结果显示农村患者死亡率高于非农村患者(53% vs 42%,P < .0001),农村居住与放疗不依从及更差总生存相关。
要点
- 农村患者死亡率高于非农村患者(53% vs 42%,P < .0001)。
- 以缺失分次数占比定义不依从时模型拟合与生存预测最佳。
- 农村居住且治疗延迟者死亡风险约为非农村且延迟者的两倍以上。
核心结论
- 在geographic与种族多样化人群中,放疗不依从是影响生存且可改变的风险因素,农村居住与放疗不依从及更差总生存相关。
- 农村且治疗延迟的患者总生存最低,低于非农村生存者及无延迟的农村生存者;作者认为农村居民启动治疗延迟者结局风险升高,应接受针对性支持以减轻观察到的差异。
- 作者指出可能从针对性治疗依从支持中获益的其他人群包括丧偶患者以及4期癌症或肺癌患者。
研究设计与样本
- 研究类型为在一家安全网学术医学中心开展的注册、病历与理赔数据研究,共识别3077例癌症患者。
- 患者平均62岁,59%为女性,34%为黑人,14%为农村;农村与否按美国农业部2013年城乡连续谱代码定义。
- 采用Cox比例风险模型考察7种不依从操作性定义,并选择模型拟合统计量与死亡预测最佳的定义。
- 总生存率用Kaplan-Meier法估计,生存评估截至2021年12月31日,平均随访4.5年。
- 随后以不依从为主要暴露并纳入其他协变量行最小绝对收缩与选择算子惩罚生存分析,并以不依从为结局行多变量广义线性回归分析。
主要发现
- 22%的患者至少缺失2次分次治疗,平均缺失治疗计划的10%。
- 农村患者死亡率高于非农村患者(53% vs 42%,P < .0001)。
- 以缺失分次数占比作为不依从指标时,模型拟合统计量与生存预测最佳。
- 婚姻状况、就业状况、TNM分期、癌症类型与诊断时年龄显著影响生存,此外还存在治疗延迟与地理居住的交互效应。
- 农村地区发生治疗延迟的患者死亡可能性为非农村地区同样发生治疗延迟者的两倍以上,且接近无治疗延迟农村居民的兩倍;非农村无治疗延迟者2年生存率为76%,农村有治疗延迟者为27%。
临床怎么用
- 原文结论指出,农村居民启动治疗延迟者结局风险升高,应接受针对性支持以减轻观察到的差异。
- 作者认为可能从针对性治疗依从支持中获益的其他人群包括丧偶患者以及4期癌症或肺癌患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cancer treatment nonadherence is associated with higher rates of cancer recurrence and decreased survival. Rural patients with cancer experience a 10% higher mortality rate compared with their nonrural counterparts; geographic differences in nonadherence may contribute to this increased mortality. The goal of this study was to assess for geographic disparities and determine sociodemographic and clinical factors associated with radiation therapy (RT) nonadherence and survival among rural and nonrural patients with cancer. METHODS AND MATERIALS: We examined cancer registry, medical records, and billing claims data at a safety net academic medical center. Geographic residence was defined as rural versus nonrural by US Department of Agriculture 2013 Rural-Urban Continuum Codes. Other factors assessed were age, sex, race, marital status, insurance type, employment, area median household income, residential distance to cancer treatment center, clinical stage, cancer type, treatment modality, total radiation dose received, and radiation dose per fraction. We used Cox proportional hazards modeling to examine 7 ways of operationalizing nonadherence and selected the definition that resulted in the best model fit statistics and prediction of mortality. Overall survival rates were estimated with the Kaplan-Meier method. We then examined nonadherence as the main exposure along with additional covariates in least absolute shrinkage and selection operator penalized survival analyses and as the outcome in our multivariable generalized linear regression analyses predicting nonadherence. We considered 2-way interaction terms with the main exposure, geographic residence. RESULTS: We identified 3,077 patients with cancer who averaged 62 years old, were 59% female, 34% Black, and 14% rural. Twenty-two percent of patients missed at least 2 fractions and missed an average of 10% of their treatment plan. Rural patients experienced a higher mortality rate than nonrural patients (53% vs 42%, P < .0001). Survival was assessed through December 31, 2021, with a mean follow-up of 4.5 years. Proportion of missed fractions as the indicator of nonadherence provided the best model fit statistics and prediction of survival. Marital status, employment status, tumor, nodes, metastases stage, cancer type, and age at diagnosis significantly affected survival, in addition to a treatment delay by geographic residence interaction effect. Specifically, patients residing in rural areas who experienced a treatment delay were more than twice as likely to die as nonrural residents who also experienced a treatment delay, and nearly twice as likely to die as rural residents who did not experience a treatment delay. The 2-year survival rate was 76% for nonrural residents who did not experience a treatment delay versus 27% for rural residents who experienced a treatment delay. Patients who were widowed, had stage 4 cancer, or lung cancer were more likely to be nonadherent. Finally, patients residing in rural areas who experienced a treatment delay were more likely to subsequently be nonadherent. CONCLUSIONS: In a geographically and racially diverse population, RT nonadherence is a significant concern that affects survival, yet it is a modifiable risk factor. We demonstrated that rural residence was associated with both RT nonadherence and poorer overall survival. Rural patients with a treatment delay had the lowest overall survival, compared with both nonrural survivors and rural survivors without delay. Rural residents who are delayed in starting treatment are at heightened risk for poor outcomes and should receive targeted support to mitigate the observed disparities. Additional patient populations that may benefit from targeted treatment adherence support include widowed patients and those with stage 4 cancer or lung cancer.
引用
- Morris BB, Hughes R, Fields EC, et al. Sociodemographic and Clinical Factors Associated With Radiation Treatment Nonadherence and Survival Among Rural and Nonrural Patients With Cancer. Int J Radiat Oncol Biol Phys. 2022. PMID: 35777674. doi:10.1016/j.ijrobp.2022.06.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。